Form 4 for ERAS Erasca, Inc.

Accepted 2023-12-06 00:00:00 ET · period of report 2023-12-05 · accession 0001209191-23-057681 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2023-12-06	2023-12-05+	ERAS	Lim Jonathan E	COB, CEO, Dir, 10%	P - Purchase	$1.70	+1.00M	12.90M	+8%	+$1.70M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-12-06	P	A	278,150	$1.72	12,899,360	I By City Hill, LLC	—	—	(F1) Includes purchases made on December 5, 2023, and December 6, 2023 that are reported on this Form 4. (F2) Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.
2	Common	Common Stock	2023-12-05	P	A	721,850	$1.69	12,899,360	I By City Hill, LLC	—	—	(F1) Includes purchases made on December 5, 2023, and December 6, 2023 that are reported on this Form 4. (F2) Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.